Dermatology News

Infliximab biosimilar uptake increased by no more than just 5% annually following the release of its first two biosimilars, but then shot up by 13% to 16% for most patients after a third option emerged, according to data.

The cosmetic industry is preparing for yet another rapidly approaching deadline imposed by the Modernization of Cosmetics Registration Act of 2022.

The FDA has not approved a new sunscreen ingredient since the 1990s, leaving consumers and clinicians wondering why.

Nasal colonization with Staphylococcus aureus accounted for most postoperative staph infections in a large cohort of adults who underwent surgery, according to a study published in Open Forum Infectious Diseases.

Patients who followed a plant-based diet experienced hair growth with the addition of a daily vegan nutraceutical, according to a study.

A healthy, 19-year-old noticed some pruritic, somewhat raised erythematous lesions on her left forearm (Figure 1). The middle lesion had an unusual linear appearance.

In this episode, host Hansa Bhargava, MD, talks with Julia Kerolus, MD, FACS, about the MedSpa industry, the dangers of social media and its effect on cosmetic procedures among young adults, skin care and more.

Ingesting colloidal silver supplements is popular but unsafe and, in excess, can lead to a patient’s skin permanently turning blue, according to experts.

In September 2022, the FDA approved deucravacitinib for moderate-to-severe plaque psoriasis, officially introducing tyrosine kinase 2 inhibition to clinics across the United States.